The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
gai zuo kang ji xiao ben zuo zuo he niludipine de jiang ya xiao guo
Author(s): 
Pages: 19-20
Year: Issue:  5
Journal: Progress in Japanese Medicine

Keyword:  研究阶段治疗方法钙拮抗剂治疗药物硝苯吡啶肾性高血压血管阻力降压效果反射性高血压治疗;
Abstract: <正> 一、高血压治疗进展与钙拮抗剂近年来随着高血压病因探讨的不断深入,其治疗方法也有很大的进展。此类药物主要用于重症高血压治疗。从作用机制来看,属于血管扩张剂,但其真正的降压机理仍处于研究阶段。目前主要的钙拮抗剂有硝苯吡啶(Nifedipine)、Niludipine(硝苯吡啶的衍生物)、硫氮(艹卓)酮(Diltiazem)、异搏定(Verapamil)、双苯丙胺(Prenylamine)、双环己哌啶(Perhexiline)。
Related Articles
No related articles found